Pharmaceuticals — Editors

Journal Contact

Pharmaceuticals Editorial Office
MDPI AG, Klybeckstrasse 64, 4057 Basel, Switzerland
Tel. +41 61 683 77 34; Fax: +41 61 302 89 18

Editorial Office

Dr. Jean Jacques Vanden Eynde
Formerly head of the Department of Organic Chemistry (FS), University of Mons-UMONS, 7000 Mons, Belgium
Tel. + 32 65 352589
Interests: heterocycles; microwave-induced synthesis; medicinal chemistry; green chemistry

Associate Editor
Dr. Annie Mayence
Formerly professor at the Haute Ecole Provinciale de Hainaut-Condorcet, 7330 Saint-Ghislain, Belgium
Tel. +3 265 335 2589

Associate Editor
Prof. Dr. Shin Mineishi
Director, Bone Marrow Transplantation and Cell Therapy Program, Division of Hematology & Oncology, The University of Alabama at Birmingham, 1802 6th Avenue South, NP 2562, Birmingham, AL 35294-3300, USA
Interests: bone marrow transplantation; graft versus host disease; complications after stem cell transplantation; reduced intensity stem cell transplantation; HLA-mismatch stem cell transplantation; graft engineering; cell therapy; and gene therapy

Former Editor-in-Chief
Dr. Derek J. McPhee *
Director of Chemistry, Amyris, Inc., 5885 Hollis St, Suite 100, Emeryville, CA 94608, USA
Tel. +1 510 450 0761 xt 718; Fax: +1 510 225 2645
Interests: organic synthesis; medicinal chemistry; biotechnology
* Founding Editor-in-Chief and Editor-in-Chief up to 29 January 2015.

Assistant Managing Editor
Ms. Changzhen Fu
MDPI Wuhan Office, No.6 Jingan Road, 5.5 Creative Industry Park, Floor 25th. 430064 Wuhan, Hubei Province, China
Tel. +86-27-87808658; Fax: +86-27-87612588

Production Editor
Dr. Martyn Rittman
MDPI AG, Klybeckstrasse 64, CH-4057 Basel, Switzerland

Editorial Board

Prof. Dr. Peter J. Barnes
National Heart and Lung Institute, Imperial College, London, UK
Tel. +44 207 351 8174; Fax: +44 207 351 5675
Interests: molecular mechanisms and therapy of asthma and COPD
Contribution: Special Issue: Antiasthmatic Drugs

Dr. Ian Churcher
Discovery Medicinal Chemistry, GlaxoSmithKline Medicines Research Centre, Gunnels Wood Road, Stevenage, SG1 2NY, UK
Tel. +44 1438 762468; Fax: +44 1438 768232
Interests: fragment-based drug design; structure-based design; kinases; pharmacokinetics; novel hit identification strategies; screening techniques and chemical diversity

Prof. Dr. Paul Cos
Laboratory of Microbiology, Parasitology and Hygiene (LMPH), Department of Pharmaceutical Sciences, Faculty of Pharmaceutical, Biomedical and Veterinary Sciences Antwerp University, campus drie eiken, building S, office 7.26 Universiteitsplein 1, B-2610 Antwerp, Belgium
Interests: anti-infective agents; biofilm; bacterial virulence; oxidative stress; antibacterial; antifungal; antiparasitic and antiviral
Contribution: Special Issue: Anti-Infective Agents
In other journals:
Special Issue: Anti-Infective Agents

Prof. Dr. Thomas Efferth
Department of Pharmaceutical Biology, Institute of Pharmacy and Biochemistry, University of Mainz, Staudinger Weg, 555128 Mainz, Germany
Tel. +49 6131 3925751; Fax: +49 6131 3923752
Interests: cancer; pharmacogenomics; molecular docking and virtual drug screening; molecular pharmacology; natural products; phytotherapy
Contribution: Special Issue: Phytomedicine

Dr. Arthur Gomtsyan
Abbvie Inc, Drug Discovery, 1 North Waukegan Road, Department ZR09, Bldg. AP10, North Chicago, IL 60064, USA
Tel. +1 847 935 4214; Fax: +1 847 937 9195
Interests: medicinal chemistry; synthetic organic chemistry; drug design in the area of pain and dermatology research
Contribution: Special Issue: Advances in Drug Design

Dr. Gilles Gosselin
CNRS Research, Idenix Senior Scientist Fellow, Laboratoires IDENIX Sarl, Cap Gamma, 1682 Rue de la Valsière, B.P. 50001, 34189 Montpellier, Cedex 4, France
Tel. +33 (0)4 99 64 27 31; +33 (0)6 27 78 32 62 (mobile); Fax: +33 (0)4 67 63 73 26
Interests: new nucleoside analogues as potential antiviral (AIDS, hepatitis) and antumor agents; nucleoside prodrugs; nucleotide prodrugs (pronucleotides)

Prof. Dr. Bernd Groner
Georg Speyer Haus, Institute for Biomedical Research, Paul Ehrlich Str. 42, D-60596 Frankfurt am Main, Germany
Tel. +49 69 63395180; Fax: +49 69 63395185
Interests: cytokine signal transduction; peptide inhibitors of oncoproteins; breast cancer research; experimental tumor therapy
Contribution: Special Issue: Peptide Drug Discovery and Development

Dr. Rick Gussio
National Cancer Institute, Division of Cancer Treament and Diagnosis, Developmental Therapeutics Program, Information Technology Branch, Target Structure-Based Drug Discovery Group, Frederick National Laboratory of Cancer Research, 8490 Progress Drive Riverside 5, Suite 400 Frederick, MD 21701, USA
Tel. +1 301 846 5791; Fax: +1 301 846 6106
Interests: structural medicinal chemistry; structure-based design & discovery; molecular modeling, bioinformatics; chemoinformatics; applied statistics; QSAR; computational chemistry; pharmacognosy

Prof. Dr. Michael Gütschow
Pharmaceutical Institute, University of Bonn, An der Immenburg 4, 53115 Bonn, Germany
Tel. +49 228 732317
Interests: synthetic organic chemistry; enzyme kinetics; mechanism-based enzyme inhibitors; inhibitors of proteases

Prof. Dr. Christian Hartinger
School of Chemical Sciences, The University of Auckland, Private Bag 92019, Auckland 1142, New Zealand
Interests: development of metal-based drugs; mode of action studies; interaction with biomolecules and bioanalytical chemistry with a focus on mass spectrometric techniques coupled to separation methods

Dr. Kenneth A. Jacobson
Laboratory of Bioorganic Chemistry and Molecular Recognition Section, National Institute of Diabetes & Digestive & Kidney Diseases, National Institutes of Health, Bldg. 8A, Rm. B1A-19, 8 Center Dr., MSC-0810 Bethesda, MD 20892-0810, USA
Tel. +1 301 496 9024; Fax: +1 301 496 9024
Interests: medicinal chemistry; G protein-coupled receptors; receptor pharmacology; cell signaling; molecular modeling; purinergic receptors; adenosine receptors; chemistry of nucleosides and nucleotides; radiochemistry; nanotechnology and nanoscience

Dr. Svend Borup Jensen
Nuklearmedicinsk Afdeling - Hobrovej 18-22, Postboks 365, 9100 Aalborg, Denmark
Tel. +45 9766 5495
Interests: PET-radiochemistry, gallium-68, drug degradation profiles; medicinal gum; infection imaging, analytical methods; medicinal chemistry
Contribution: Special Issue: Radiochemistry
Special Issue: Preparation of Radiopharmaceuticals and Their Use in Drug Development
In other journals:
Special Issue: Radiochemistry
Special Issue: Preparation of Radiopharmaceuticals and Their Use in Drug Development

Prof. Dr. Klaus Kopka
Division of Radiopharmaceutical Chemistry, Research Program Imaging and Radiooncology, German Cancer Research Center (dkfz), Im Neuenheimer Feld 280, D-69120 Heidelberg, Germany
Interests: radiopharmaceutical sciences; labeling chemistry; medicinal chemistry; PET tracers; radiopharmaceuticals for diagnostics and endoradiotherapy; small molecules; peptides; antibodies and derivatives thereof
Contribution: Special Issue: Radiopharmaceutical Chemistry between Imaging and Radioendotherapy

Prof. Dr. Peter A. Leggat
College of Public Health, Medical and Veterinary Sciences, Faculty of Medicine, Division of Tropical Health and Medicine, James Cook University, Townsville Qld 4811, Australia
Interests: tropical and travel medicine; neglected tropical diseases; malaria; aerospace and occupational medicine
Contribution: Special Issue: Tropical Medicine

Prof. Dr. Philip S. Low
Department of Chemistry, Purdue University, 560 Oval Drive, West Lafayette, IN 47906-2084, USA
Tel. +1 765 494 5273; Fax: +1 765 494 5272
Interests: targeted therapies for inflammatory and autoimmune diseases; targeted therapies for cancer; structure of the erythrocyte membrane; siRNA delivery; ligand-targeted imaging agents; nanomedicines; rapid detection and identification of pathogens

Prof. Dr. Giuseppe Mancia
Clinical Medicine Unit, University of Milano-Bicocca, San Gerardo Hospital, Via Pergolesi, 33, 20052 Monza (MI), Italy
Tel. +39 039 2333357; Fax: +39 039 322274
Interests: pathophysiology; clinical pharmacology and therapy of hypertension; congestive heart failure and other cardiovascular diseases
Contribution: Special Issue: Antihypertensive Drugs

Prof. Dr. Alberto M. Martelli
Dipartimento di Scienze Anatomiche Umane, Università di Bologna, Cell Signalling Laboratory, School of Pharmacy, via Irnerio 48, 40126 Bologna BO, Italy
Tel. +39 051 2091580; Fax: +39 051 2091695
Interests: targeted therapies for cancer; signal transduction pathways as innovative therapeutic targets; nuclear lipid-based signaling

Prof. Dr. Kevin H. Mayo
Department of Biochemistry, Molecular Biology & Biophysics, and the NCI-designated Comprehensive Cancer Center, University of Minnesota, Minneapolis, Minnesota 55455, USA
Tel. +1 612 625 9968
Interests: protein and carbohydrate structure and function; NMR spectroscopy; structure-based drug design and discovery; angiogenesis; oncology; infectious disease

Prof. Dr. Jane McHowat
Department of Pathology, Saint Louis University School of Medicine, Schwitalla Hall, Room M207, 1402 S. Grand Blvd, St. Louis, MO 63104, USA
Interests: inflammation, phospholipases, breast cancer, interstitial cystitis, bladder, atherosclerosis, platelet-activating factor Contribution: Topical Collection: Non-Steroidal Anti-Inflammatory Drugs
Contribution: Topical Collection: Non-Steroidal Anti-Inflammatory Drugs

Prof. Dr. Paolo Montuschi
Department of Pharmacology, Faculty of Medicine, Catholic University of the Sacred Heart, Largo Francesco Vito 1, 00168 Rome, Italy
Tel. +39 06 30156092; Fax: +39 06 30156292
Interests: asthma; chronic obstructive pulmonary disease (COPD); pharmacological therapy of asthma and COPD; allergy; non-invasive monitoring of lung inflammation; exhaled breath condensate; exhaled nitric oxide; electronic nose; metabolomics
Contribution: Special Issue: Antiasthmatic Drugs

Dr. Mark Murphy
Research Immunology, Actelion Pharmaceuticals Ltd, Gewerbestrasse 16, CH- 4123 Allschwil, Switzerland
Tel. +41 61 565 85 12
Interests: immunology; targeted therapies for inflammatory and autoimmune diseases; signal transduction pathways as innovative therapeutic targets; stem cells; protein-protein interactions; targeted therapies for cancer; cytokines/chemokines
Contribution: Special Issue: Chemokines

Dr. Mark H. Norman
Therapeutic Discovery Amgen Inc., One Amgen Center Drive, MS: B29 29-M-B Thousand Oaks, CA 91320-1799, USA
Tel. +1 805 447 1552; Fax: +1 805 480 3015
Interests: design and synthesis of new chemical entities (NCE) towards several targets mainly connected with cancer, pain and inflammation; lead discovery and optimization; medicinal chemistry

Dr. Emmanuel S. Onaivi
Department of Biology, William Paterson University, Wayne, NJ, 07470, USA
Tel. +1 973 720 3453
Interests: cannabinoids; endocannabinoid system; cannabinoid genetics and epigenetics; drug addiction; medical marijuana and cannabinoid pharmacogenomics
Contribution: Special Issue: Medical Marijuana

Prof. Dr. Ricardo E. Pérez-Tomás
Department of Pathology and Experimental Therapy, Faculty of Medicine, University of Barcelona, Campus de Bellvitge., Lab.5101 C./ Feixa Llarga s/n E- 08907, Hospitalet de Llobregat, Barcelona, Spain
Tel. +34 93 4024288; Fax: +34 93 4024249
Interests: new molecules for cancer chemotherapy; apoptosis; signal transduction for cancer chemotherapy

Prof. Dr. Yvonne Perrie
Aston Pharmacy School, School of Life and Health Sciences, Aston University, Aston Triangle, Birmingham, B4 7ET, UK
Interests: liposomes; gene therapy; vaccines; colloidal systems; pharmaceutics; pharmaceutical education; drug delivery
Contribution: In other journals:
Special Issue: What's on Board in Pharmaceutics
Special Issue: Gene Therapy
Special Issue: Feature Papers: Emerging Processes, Analytics and Dosage Forms in Pharmaceutical Processing and Drug Delivery

Prof. Dr. Leonidas A. Phylactou
Acting Chief Executive Medical Director, The Cyprus Institute of Neurology & Genetics, PO Box 23462, 1683 Nicosia, Cyprus
Interests: RNA biology; regulatory RNA molecules; muscle regeneration, identification of genetic defects in inherited diseases
Contribution: Special Issue: Gene Therapy
Special Issue: Towards Understanding the Mechanisms and Curing Of Muscular Dystrophy Diseases
In other journals:
Special Issue: Towards Understanding the Mechanisms and Curing Of Muscular Dystrophy Diseases

Prof. Dr. Maurizio Pompili
Department of Neurosciences, Mental Health and Sensory Functions, Suicide Prevention Center, Sant'Andrea Hospital, Sapienza University of Rome, Via Grottarossa 1037, 00189, Rome, Italy
Interests: Suicide and suicidal behavior; suicide prevention strategies

Prof. Dr. Dr. Thomas Rades
Reseach Chair in Pharmaceutical Design and Drug Delivery Faculty of Health and Medical Sciences, Department of Pharmacy, University of Copenhagen, Universitetsparken 2, 2100 København Ø, Denmark
Interests: the solid state of drugs and dosage forms; poorly water soluble drugs; amorphous drugs and drug delivery systems; lipid based drug delivery systems; analytical techniques in the solid state
Contribution: In other journals:
Special Issue: Poorly Soluble Drugs

Prof. Dr. Maurizio Recanatini
Department of Pharmaceutical Sciences, University of Bologna, Via Belmeloro 6, I-40126 Bologna, Italy
Tel. +39 051 20 99720; Fax: +39 051 20 99734
Interests: computational medicinal chemistry; structure-based ligand design & discovery; modeling of targets and ligand-target complexes of therapeutic interest (cancer, Alzheimer\'s disease, hERG-related drug toxicity); chemical biology
Contribution: Special Issue: Targeted Therapy

Dr. P. Hemachandra Reddy
Executive Director and Chief Scientific Officer of Garrison Institute on Aging, Professor of Cell Biology & Biochemistry, Neuroscience & Pharmacology and Neurology Departments, Texas Tech University Health Science Center, 3601 4th Street/MS/9424/4A 124, Lubbock, Texas 79430, USA
Tel. +806 743 2385; Fax: +1 503 418 2501
Interests: aging; neurodegenerative diseases; gene expression analysis; transgenic mouse models; mitochondrial biology; mitochondrial function/dysfunction; mitochondrial therapeutics; mitochondrial dynamics Contribution: Special Issue: Mitochondrial Drugs for Neurodegenerative Diseases Special Issue: Genes, Mechanisms and Drugs for Asthma
Contribution: Special Issue: Mitochondrial Drugs for Neurodegenerative Diseases
Special Issue: Genes, Mechanisms and Drugs for Asthma

Prof. Dr. Oliver Reiser
Institut für Organische Chemie, Universität Regensburg, Universitätsstr. 31, 93053 Regensburg, Germany
Tel. +49 (0)941 943 4631(4630); Fax: +49 (0)941 943 4121
Interests: asymmetric catalysis; stereoselective synthesis; natural product; synthesis; unnatural amino acids; foldamers
Contribution: Special Issue: Asymmetric Synthesis and Medicinal Chemistry

Prof. Dr. Domenico Ribatti
Dipartimento di Scienze Mediche di Base,Sezione di Anatomia Umana e Istologia, Università degli Studi di Bari, Piazza G. Cesare 11, Policlinico, 70124 Bari, Italy
Tel. +39 080 5478240; Fax: +39 080 5478310
Contribution: Special Issue: Angiogenesis Inhibitors

Dr. Maria Emília Sousa
Faculdade de Farmácia da Universidade do Porto Rua de Jorge Viterbo Ferreira, 228 4050-313 Porto, Portugal
Tel. +351 220 428 586; Fax: +351 226 093 390
Interests: medicinal chemistry; organic synthesis; heterocycles, chiral drugs; anticancer; anticoagulants; P-glycoprotein

Prof. Dr. Vladimir P. Torchilin
Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Mugar Building, Rm 312, 360 Huntington Avenue, Boston, MA 02129, USA
Tel. +617 373 3206; Fax: +617 373 7509
Interests: Drug carriers, Drug delivery sytems, Drug targeting, Liposomes, Micelles, Experimental cancer immunology, Imaging agents
Contribution: Special Issue: Cell-penetrating Peptides
In other journals:
Special Issue: Biodegradability of Materials
Special Issue: Biodegradability of Materials
Special Issue: Micellar Drug Delivery

Dr. Sonia Tucci
School of Psychology, University of Liverpool, Eleanor Rathbone Building, Bedford Street South, Liverpool, L37 2LE, UK
Tel. +44 151 7941121; Fax: +44 151 794 2945
Interests: behavioural neuroscience; psychopharmacology; neurochemical correlates of behaviour; mechanisms of appetite regulation; brain cannabinoid function in relation to appetite and body weight regulation
Contribution: Special Issue: Phytochemicals with actions on the Central Nervous System

Dr. Guangshun Wang
Department of Pathology & Microbiology University of Nebraska Medical Center, USA
Interests: Host defense antimicrobial peptides, Structural bioinformatics, Biomolecular NMR
Contribution: Topical Collection: Identification and Characterization of Antimicrobial Peptides with Therapeutic Potential

Dr. Howard A. Young
Principal Investigator & Deputy Lab Chief, Laboratory of Experimental Immunology, Cancer and Inflammation Program, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Bldg. 560/31-23, Chandler Street, Frederick, MD 21702-1201, USA
Tel. +1 301 846 5743; Fax: +1 301 846 1673
Interests: interferon-gamma; post transcriptional regulation; NK cells; interleukins
Contribution: Special Issue: Interferons
Special Issue: Interferons 2015
In other journals:
Special Issue: Cytokines in Cancer

Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert